<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02387060</url>
  </required_header>
  <id_info>
    <org_study_id>13-389</org_study_id>
    <nct_id>NCT02387060</nct_id>
  </id_info>
  <brief_title>Use of Intrathecal Fentanyl and Development of Hyperalgesia in Patients Undergoing Elective Cesarean</brief_title>
  <official_title>Use of Intrathecal Fentanyl and Development of Hyperalgesia in Patients Undergoing Elective Cesarean</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Pontificia Universidad Catolica de Chile</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Pontificia Universidad Catolica de Chile</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Opioid analgesic drugs are the main treatment of patients during anesthesia. Although highly&#xD;
      effective, their use is not without problems. One is the increasing requirement of these&#xD;
      address the same nociceptive stimulus.&#xD;
&#xD;
      Opioid induced hyperalgesia could be an explanation studies in animal models. Through&#xD;
      mechanisms where N-methyl-D-aspartate receptors, glutamatergic system disturbances and&#xD;
      changes in intracellular calcium regulation involved.&#xD;
&#xD;
      The hyperalgesia induced by intrathecal opioids is controversial. The investigators propose a&#xD;
      model study in patients undergoing cesarean section to study the secondary hyperalgesia&#xD;
      induced based on the study of nociceptive thresholds with two methods opioids: Von Frey&#xD;
      filaments and digital algometer.&#xD;
&#xD;
      If intrathecal fentanyl is used in spinal anesthesia for elective cesarean section, then, an&#xD;
      increase in sensitivity will occur. This increase can be measured by von Frey filaments,&#xD;
      expressed in increased requirement clinically opioids.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>August 2014</start_date>
  <completion_date type="Anticipated">January 2016</completion_date>
  <primary_completion_date type="Anticipated">December 2015</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in Punctate - Von frey (grams)</measure>
    <time_frame>Change from Baseline in punctate sensibility at 48 hours</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in Pressure pain - algometer (kg/cm/cm)</measure>
    <time_frame>Change from Baseline in pressure pain at 48 hours</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">80</enrollment>
  <condition>Complications; Cesarean Section</condition>
  <arm_group>
    <arm_group_label>H-Bupivacaine 11.5 mg + fentanyl 25 mcg.</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Intrathecal administration of Hyperbaric Bupivacaine 1.5 ml 0.75% plus fentanyl 25 mcg.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>H-Bupivacaine 11.5 mg.</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Intrathecal administration of Hyperbaric Bupivacaine 1.5 ml 0.75%</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>H-Bupivacaine</intervention_name>
    <description>Intrathecal administration of hyperbaric bupivacaine 1.5 ml 0.75%</description>
    <arm_group_label>H-Bupivacaine 11.5 mg + fentanyl 25 mcg.</arm_group_label>
    <arm_group_label>H-Bupivacaine 11.5 mg.</arm_group_label>
    <other_name>Hyperbaric bupivacaine</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Fentanyl</intervention_name>
    <description>Intrathecal administration of fentanyl 25 mcg</description>
    <arm_group_label>H-Bupivacaine 11.5 mg + fentanyl 25 mcg.</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Pregnant 37 to 41 weeks.&#xD;
&#xD;
          -  American Society of Anesthesiologists classificationI or II.&#xD;
&#xD;
          -  Between 18 and 40 years.&#xD;
&#xD;
          -  Scheduled for elective cesarean section under spinal anesthesia in the Maternity&#xD;
             Service of the Clinical Hospital of the Catholic University.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Background Of high risk pregnancy. Twin-pregnancy.&#xD;
&#xD;
          -  Obesity&gt; 30 kg / m 2 before pregnancy.&#xD;
&#xD;
          -  Background Of psychiatric illness.&#xD;
&#xD;
          -  Using Chronic analgesic.&#xD;
&#xD;
          -  AllergyDrug used in protocol.&#xD;
&#xD;
          -  require General anesthesia during surgery&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Luis I Cortinez, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Ponticia Universidad Católica</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Juan Carlos De la Cuadra, MD</last_name>
    <phone>+56-2-23543270</phone>
    <email>juancarl@med.puc.cl</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Hernan Auad, MD</last_name>
    <phone>+56-2-23543270</phone>
    <email>hernan_auad@hotmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Hospital Clinico Pontificia Universidad Catolica</name>
      <address>
        <city>Santiago</city>
        <state>Región Metropolitana</state>
        <zip>8330024</zip>
        <country>Chile</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hernan Auad, MD</last_name>
      <phone>56982933226</phone>
      <email>hernan_auad@hotmail.com</email>
    </contact>
    <investigator>
      <last_name>Juan Carlos de la Cuadra, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Chile</country>
  </location_countries>
  <verification_date>March 2015</verification_date>
  <study_first_submitted>February 25, 2015</study_first_submitted>
  <study_first_submitted_qc>March 7, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 12, 2015</study_first_posted>
  <last_update_submitted>March 7, 2015</last_update_submitted>
  <last_update_submitted_qc>March 7, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 12, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Anesthesia</keyword>
  <keyword>Spinal and Epidural</keyword>
  <keyword>Adverse Effect</keyword>
  <keyword>Complications</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hyperalgesia</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fentanyl</mesh_term>
    <mesh_term>Bupivacaine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

